Yeagley M - Search Results

1

The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma.

McBride MJ, Pulice JL, Beird HC, Ingram DR, D'Avino AR, Shern JF, Charville GW, Hornick JL, Nakayama RT, Garcia-Rivera EM, Araujo DM, Wang WL, Tsai JW, Yeagley M, Wagner AJ, Futreal PA, Khan J, Lazar AJ, Kadoch C. McBride MJ, et al. Among authors: yeagley m. Cancer Cell. 2018 Jun 11;33(6):1128-1141.e7. doi: 10.1016/j.ccell.2018.05.002. Epub 2018 May 31. Cancer Cell. 2018. PMID: 29861296 Free PMC article.

2

Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor.

Bhalla AD, Landers SM, Singh AK, Landry JP, Yeagley MG, Myerson GSB, Delgado-Baez CB, Dunnand S, Nguyen T, Ma X, Bolshakov S, Menegaz BA, Lamhamedi-Cherradi SE, Mao X, Song X, Lazar AJ, McCutcheon IE, Slopis JM, Ludwig JA, Lev DC, Rai K, Torres KE. Bhalla AD, et al. Among authors: yeagley mg. Lab Invest. 2022 Jun;102(6):658-666. doi: 10.1038/s41374-022-00734-6. Epub 2022 Feb 28. Lab Invest. 2022. PMID: 35228656 Free article.

3

Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas.

Yeagley M, Chobrutskiy BI, Gozlan EC, Medikonda N, Patel DN, Falasiri S, Callahan BM, Huda T, Blanck G. Yeagley M, et al. Pediatr Hematol Oncol. 2021 Apr;38(3):251-264. doi: 10.1080/08880018.2020.1843576. Epub 2021 Feb 22. Pediatr Hematol Oncol. 2021. PMID: 33616477

4

Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates.

Arturo JF, Chobrutskiy BI, Yeagley M, Patel DN, Falasiri S, Patel JS, Blanck G. Arturo JF, et al. Among authors: yeagley m. Cell Mol Immunol. 2020 Jul;17(7):776-778. doi: 10.1038/s41423-019-0328-8. Epub 2019 Nov 15. Cell Mol Immunol. 2020. PMID: 31729463 Free PMC article. No abstract available.

5

Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma.

Chobrutskiy BI, Yeagley M, Tipping P, Zaman S, Diviney A, Patel DN, Falasiri S, Uversky VN, Blanck G. Chobrutskiy BI, et al. Among authors: yeagley m. Oncogene. 2020 Feb;39(8):1773-1783. doi: 10.1038/s41388-019-1101-2. Epub 2019 Nov 18. Oncogene. 2020. PMID: 31740784

6

A scoring system for the electrostatic complementarities of T-cell receptors and cancer-mutant amino acids: multi-cancer analyses of associated survival rates.

Chobrutskiy BI, Yeagley M, Diviney A, Zaman S, Gozlan EC, Tipping P, Koohestani DM, Roca AM, Blanck G. Chobrutskiy BI, et al. Among authors: yeagley m. Immunology. 2020 Apr;159(4):373-383. doi: 10.1111/imm.13165. Epub 2020 Jan 21. Immunology. 2020. PMID: 31821535 Free PMC article.

7

TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.

Arndt MF, Koohestani DM, Chobrutskiy BI, Mihyu MM, Diaz M, Gozlan EC, Yeagley M, Zaman S, Roca AM, Blanck G. Arndt MF, et al. Among authors: yeagley m. Hum Immunol. 2020 Dec;81(12):692-696. doi: 10.1016/j.humimm.2020.08.007. Epub 2020 Sep 16. Hum Immunol. 2020. PMID: 32950267

8

High-throughput, sliding-window algorithm for assessing chemical complementarity between immune receptor CDR3 domains and cancer mutant peptides: TRG-PIK3CA interactions and breast cancer.

Chobrutskiy BI, Chobrutskiy A, Zaman S, Yeagley M, Huda TI, Blanck G. Chobrutskiy BI, et al. Among authors: yeagley m. Mol Immunol. 2021 Jul;135:247-253. doi: 10.1016/j.molimm.2021.02.026. Epub 2021 Apr 29. Mol Immunol. 2021. PMID: 33933816

9

A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma.

Patel DN, Yeagley M, Arturo JF, Falasiri S, Chobrutskiy BI, Gozlan EC, Blanck G. Patel DN, et al. Among authors: yeagley m. Int J Immunogenet. 2021 Oct;48(5):409-418. doi: 10.1111/iji.12550. Epub 2021 Jul 23. Int J Immunogenet. 2021. PMID: 34298587

10

Systemic Adaptive Immune Parameters Associated with Neuroblastoma Outcomes: the Significance of Gamma-Delta T Cells.

Gozlan EC, Chobrutskiy BI, Zaman S, Yeagley M, Blanck G. Gozlan EC, et al. Among authors: yeagley m. J Mol Neurosci. 2021 Nov;71(11):2393-2404. doi: 10.1007/s12031-021-01813-x. Epub 2021 Mar 5. J Mol Neurosci. 2021. PMID: 33666857

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page